© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#Truvada

POZ March 2019 cover U=U Undetectable = Untransmitable
How Well Do U=U and PrEP Work? The CDC Updates Its Answers
Truvada (tenofovir disoproxil fumarate + emtricitabine) 101
Chart of Approved and Experimental HIV Medications

New Twist in the Gilead Patent Lawsuit Over Truvada and Descovy to Prevent HIV

The U.S. government and HIV drugmaker Gilead Sciences continue to fight over patents for Truvada and Descovy as PrEP.

U.S. Government Updates Pregnancy and Perinatal HIV Guidelines

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.

In Scotland, PrEP Is Tied to Population-Level Decline in HIV

Researchers found that Truvada as pre-exposure prophylaxis greatly reduced HIV cases in both people on PrEP and those not on it.

Why More Health Insurers Will Soon Cover PrEP for HIV Prevention

“All insurers failing to offer PrEP without cost sharing beginning in January 2021 are clearly not following the law.”
Megen Vo, MD and Geoff Hart-Cooper, MD, of the virtual PrEP program for youth at Stanford Children’s Health

Youth in California Can Virtually Access PrEP to Prevent HIV

A new PrEP telehealth system at Stanford Children’s Health offers HIV prevention to youth and adults 25 and younger.

Doctor-Patient Shared Decision-Making Can Help Guide PrEP Use Choices

At a recent conference, a leading infectious disease provider in New York City advocated this as a means of improving patient satisfaction.

Prevention: Generic Truvada

The first generic Truvada is now available in the United States.

Merck Launches Major Trial of Monthly Islatravir PrEP Pill for Women

The company also has plans to study monthly islatravir’s efficacy as HIV prevention among men who have sex with men.

For Women, Injectable Cabotegravir Is More Effective Than Truvada as PrEP

Long-acting injectable cabotegravir for HIV prevention could hit the market for men and women in early 2022.

Black Women’s Uptake of PrEP Hampered by Numerous Factors

A qualitative study of Black women at risk for HIV in Milwaukee found that low perceived risk and medical mistrust were major barriers.

Study Sheds Light on Weight Gain After Switching to New Tenofovir

This may reflect loss of the weight-suppressing effect of the older version of the drug.

Dovato Posts 3-Year Marks on Par With Tivicay Plus Truvada as HIV Treatment

ViiV’s two-drug Dovato also boasted a high genetic barrier to the development of viral resistance.

Truvada Tied to Changes in Gut-Based Immunity

Researchers studied people taking Truvada as PrEP and plan to conduct similar research on newer antiretrovirals.

Switching HIV Regimen to Biktarvy Is Safe and Effective for the Long Term

Gilead Sciences presented findings from several studies of the single-tablet antiretroviral regimen at a recent scientific meeting.

Does Truvada Offer Protection Against COVID-19?

Studies of the link between tenofovir use and coronavirus infection or COVID-19 outcomes have yielded mixed results.

First Generic Truvada Now Available in the United States

Teva’s new version of TDF and emtricitabine doesn’t offer much of a price break, but that could come next spring.
Advertisement
Treatment News
Blog: Undetectable = Untransmittable